Schedule 13G ownership disclosure

REVOLUTION MEDICINES INC COM

Security class unavailable · CUSIP: 76155X100

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
14,634,391
Percent of class
8.9300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-021836
Form type
SC 13G/A
Filer
Revolution Medicines, Inc.
CIK
CIK 1628171
Filed
Feb 13, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub